Forecast & Rating16 analysts currently cover Sabra Healthcare Reit, with about 37.5% giving a positive rating — meaning they expect the stock to rise. The average price target is $22.79, about 11.0% upside from the current price of $20.52. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 52.2% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Sabra Healthcare Reit's outlook. Data as of Sep 8, 2026; for reference only and not investment advice.
Sep 8, 2026Price forecast
$22.7911.04%
Forecast & RatingBuy
16analysts
- Strong buy31.25%
- Buy6.25%
- Hold62.50%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 7, 2026
Forecast met62.7%
Stock price$20.52
Avg. target$22.8
High target$25
Low target$19
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.